| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |